Ovid Therapeutics, Inc. (OVID)
2.20
-0.14
(-5.98%)
USD |
NASDAQ |
Nov 20, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Market Cap : 415.19M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 415.19M |
| November 19, 2026 | 441.61M |
| November 18, 2026 | 426.51M |
| November 17, 2026 | 418.96M |
| November 16, 2026 | 452.93M |
| November 13, 2026 | 479.35M |
| November 12, 2026 | 481.24M |
| November 11, 2026 | 524.64M |
| November 10, 2026 | 528.42M |
| November 09, 2026 | 537.85M |
| November 06, 2026 | 537.85M |
| November 05, 2026 | 486.90M |
| November 04, 2026 | 506.23M |
| November 03, 2026 | 443.41M |
| November 02, 2026 | 441.57M |
| October 30, 2026 | 469.28M |
| October 29, 2026 | 472.97M |
| October 28, 2026 | 452.65M |
| October 27, 2026 | 417.55M |
| October 26, 2026 | 398.15M |
| October 23, 2026 | 399.07M |
| October 22, 2026 | 437.87M |
| October 21, 2026 | 456.35M |
| October 20, 2026 | 436.02M |
| October 19, 2026 | 400.92M |
| Date | Value |
|---|---|
| October 16, 2026 | 397.22M |
| October 15, 2026 | 417.55M |
| October 14, 2026 | 404.62M |
| October 13, 2026 | 404.62M |
| October 12, 2026 | 445.26M |
| October 09, 2026 | 454.50M |
| October 08, 2026 | 432.33M |
| October 07, 2026 | 436.02M |
| October 06, 2026 | 437.87M |
| October 05, 2026 | 432.33M |
| October 02, 2026 | 439.72M |
| October 01, 2026 | 448.96M |
| September 30, 2026 | 460.04M |
| September 29, 2026 | 469.28M |
| September 28, 2026 | 454.50M |
| September 25, 2026 | 443.41M |
| September 24, 2026 | 460.97M |
| September 23, 2026 | 474.82M |
| September 22, 2026 | 509.93M |
| September 21, 2026 | 500.69M |
| September 18, 2026 | 496.99M |
| September 17, 2026 | 498.84M |
| September 16, 2026 | 495.15M |
| September 15, 2026 | 500.69M |
| September 14, 2026 | 506.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| PS Ratio | 234.37 |
| Price to Book Value | 2.090 |
| Price | 2.20 |
| Earnings Yield | -8.40% |